BeiGene, Ltd.
BeiGene, Ltd. (BGNE) Stock Overview
Explore BeiGene, Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
20.2B
P/E Ratio
296.98
EPS (TTM)
$-8.19
ROE
0.02%
BGNE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of BeiGene, Ltd. (BGNE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $137.76.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 296.98 and a market capitalization of 20.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.